Spectra Laboratories, a division of the national dialysis company Fresenius Medical Care, will soon open a new 200,000 square foot laboratory facility in Memphis. The new lab will employ more than 300 people and will be located only 15 minutes from the Memphis International Airport and the Memphis world hub operated by FedEx Corporation. The choice of Memphis for this new laboratory facility shows the importance of logistics to help shorten lab test reporting times.
MORE ON: Spectra Lab
Spectra already operates sizeable clinical laboratories on the east coast in Rockleigh, N.J., and on the west coast in Milpitas, Calif. Both laboratories are CAP-accredited and ISO 15189-accredited through the American Association for Laboratory Accreditation (A2LA).
ELLKAY AQUIRES LEGAL EASY, INC.
In a deal to improve interoperability between healthcare information technology products, Ellkay, LLC, of Elmwood Park, N.J., announced its acquisition of Legal Easy, Inc., of Tampa. Ellkay believes Legal Easy’s X-Link medical software interfacing solution will help it assist providers—including clinical laboratories—meet federal goals for interoperability, as well as reporting federal quality measures for which providers can earn incentives or penalties from the Medicare program.
- Quest Diagnostics of Madison, N.J., named Manuel O. Méndez as its Senior Vice President and Chief Commercial Officer. Méndez previously held executive positions at Qiagen, bioMérieux, OraSure Technologies, Thermo Electron, and Abbott Laboratories.
- The federal Centers for Medicare and Medicaid Services announced the appointment of Paul Mango as the new CMS Chief Principal Deputy Administrator and Chief of Staff. Mango retired from McKinsey & Company and is a veteran of the 82nd Airborne Division and a graduate of the United States Military Academy at West Point. Mango was involved in the clinical laboratory industry for several years in the 1990s. While working with The Institute for Transfusion Medicine in Pittsburgh in the mid-1990s, Mango organized the Reference Laboratory Alliance, which was a regional hospital laboratory network with 40 participating hospitals.
That’s all the insider intelligence for this report.
Look for the next briefing on Monday, October 14, 2019.
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about …
…how use of HPV vaccines in Australia since 2007 has significantly reduced cervical cancer rates. According to a study inThe Lancet, in 2018, Australia is now transitioning from cytology-based cervical screening every two years for women aged 18 to 69 years, to primary HPV testing every five years for women aged 25 to 69 and exit testing for women aged 70 to 74 years.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.